ABSTRACT. The aim of this study was to determine whether single nucleotide polymorphisms (SNPs) in APM1 contribute to disorders of lipid metabolism in hypertensive disorder complicating pregnancy (HDCP). The study included 178 pregnant women with HDCP and 243 healthy pregnant controls. Using PCR-restriction fragment length polymorphism, we detected the frequencies of genotypes, alleles, and haplotypes of two SNPs, +45T>G (rs2241766) and +276G>T (rs1501299), in APM1. We found that the SNP +276 TT genotype was significantly associated with protection against HDCP compared to the pooled G genotypes. The genotype and allele frequency distributions of SNP +276 were significantly different between the cases and controls. Single-point genotype and allele distributions in SNP +45 were not statistically different between the groups. The pooled G haplotypes were significantly overrepresented in the case group compared to the TT haplotype. Plasma adiponectin (APN)
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